美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,492.17

+31.152.13%

涨家数：5

跌家数：2

平家数：- -

市盈率：- -

高：1,493.70

开：1,460.44

低：1,460.44

收：1,461.02

数据加载中...

总览新闻资讯

市场风云突变！谁能稳坐“减肥药王”宝座？

Ofweek光电信息网

康方生物依沃西携手辉瑞ADC，国际化布局提速

【欧股“十一罗汉”｜阿斯麦收跌2.2%，Hims减肥药业务前景提振诺和诺德收涨约2.8%】周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。

Altimmune, Inc.盘中异动股价大跌5.07%报5.80美元

Viking Therapeutics, Inc.盘中异动大幅下跌5.00%

美股异动｜礼来涨超2.7% 推出10毫克剂量的小瓶装Zepbound

港股那点事

诺和诺德盘中异动快速上涨3.04%

BUZZ-礼来公司收购 Organovo FXR 项目，Organovo 公司业绩上升

礼来以折扣价提供瓶装减肥药以应对竞争

礼来美股盘前涨逾2%

每日经济新闻

BUZZ-礼来推出大剂量瓶装减肥药，股价上涨

诺和诺德(NVO)盘前涨超4% 起诉美国药品监管机构

一次宇宙级合作

礼来推出高剂量小瓶减肥药，价格比注射笔低 150 美元

诺和诺德美股盘前续涨近4%

每日经济新闻

辉瑞任命前FDA药物主管为新任首席医疗官兼执行副总裁

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4599/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1492.1732,"timestamp":1741208399999,"preClose":1461.0245,"halted":0,"volume":58200771,"delay":0,"changeRate":0.02132,"change":31.148682,"pbRate":11.780703,"amount":5513579718.723701,"amplitude":0.02276,"prevYearClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"turnoverRate":0.005514,"marketCap":1606807813984,"floatMarketCap":1490733575264,"peRate":41.703544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1493.6967,"amplitude":0.02276,"preClose":1461.0245,"low":1460.4442,"pbRate":"11.780703","latestPrice":1492.1732,"volume":58200771,"delay":0,"open":1460.4442,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"sixtyDayClose":1441.3252,"secType":"PLATE","market":"US","turnoverRate":0.005514,"peRate":41.703544,"marketCap":1606807813984,"floatMarketCap":1490733575264,"timestamp":1741208399999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514020435","title":"市场风云突变！ 谁能稳坐“减肥药王”宝座？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514020435","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514020435?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 09:54","pubTimestamp":1740534840,"startTime":"0","endTime":"0","summary":"如今，市场悄然发生变化。同时，礼来的减肥药在国内开售，区域性的销售法规出台。今年2月，诺和诺德直接将亨利医药及黄振华告上法庭，指控其涉嫌欺诈。至于交易完成后的转移资产行为，目前黄振华方面尚未出面解释。目前，诺和诺德已向新加坡法院申请，向黄振华及其企业合计索赔8.3亿美元，并要求全球范围内冻结相关资产。目前，法院仍未最终裁定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609562996308237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609562996308237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","NVO","BK4588","LU1093756325.SGD","LU0154236417.USD","BK4007","LU1093756168.USD","BK4532","BK4599","BK4585","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2514020285","title":"康方生物依沃西携手辉瑞ADC，国际化布局提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2514020285","media":"国泰君安","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514020285?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 09:15","pubTimestamp":1740532557,"startTime":"0","endTime":"0","summary":"2月24日，公司海外合作伙伴Summit Therapeutics宣布与辉瑞达成临床试验合作，有望深入挖掘依沃西联合辉瑞多款vedotin系列ADCs药物联合疗法在多种实体瘤中的巨大潜力。辉瑞为全球ADC领域头部玩家，有望提供丰富产品组合。多项临床布局推动下，依沃西有望在肺癌领域实现全线布局，与ADC的联合给药有望在长期进一步带来治疗模式的突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226093052a2541cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226093052a2541cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1883839398.USD","SG9999013999.USD","LU0868494617.USD","LU1057294990.SGD","IE00BLSP4452.SGD","LU0306807586.USD","BK4231","SG9999011175.SGD","LU0321505868.SGD","BK4592","BK4533","BK4581","IE00B19Z3581.USD","LU0058720904.USD","LU0225284248.USD","ADC","LU0170899867.USD","LU0306806265.USD","IE000M9KFDE8.USD","BK4568","LU1023059063.AUD","SG9999001176.USD","LU1894683348.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","BK4080","SG9999001176.SGD","BK4585","LU0321505439.SGD","LU0985481810.HKD","BK4534","SGXZ57979304.SGD","PFE","LU0234572021.USD","BK4599","LU1066051498.USD","LU0122379950.USD","IE00BLSP4239.USD","SG9999003800.SGD","BK4007","IE00BBT3K403.USD","LU0225771236.USD","LU0289739699.SGD","BK4588","SG9999002232.USD","LU0456855351.SGD","LU1066053197.SGD","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2514950017","title":"【欧股“十一罗汉”｜阿斯麦收跌2.2%，Hims减肥药业务前景提振诺和诺德收涨约2.8%】 周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514950017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514950017?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 01:54","pubTimestamp":1740506070,"startTime":"0","endTime":"0","summary":"周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26015448386051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4543","BK4212","LU0823434583.USD","BK4578","LU0109394709.USD","LU0211331839.USD","GSK","BK4183","IE00BJT1NW94.SGD","NVS","BK4147","LU0823434740.USD","ASML","LU2236285917.USD","IE0002141913.USD","NSRGY","IE00BFTCPJ56.SGD","LU2456880835.USD","LU1093756325.SGD","LRLCY","BK4007","IE00BD6J9T35.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU2462157665.USD","LU0097036916.USD","BK4532","03165","LU1829250122.USD","BK4568","NVO","LU0889565916.HKD","IE0004445239.USD","BK1574","LU1093756168.USD","LU2063271972.USD","AZN","BK4585","LU0154236417.USD","01477","BK4599","LU2417539215.USD","IE00B2B36J28.USD","GSK.UK","IE00BKVL7J92.USD","BK1191","IE0009355771.USD","LU1734074674.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2514148800","title":"Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514148800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514148800?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 00:32","pubTimestamp":1740501166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Altimmune, Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报5.80美元/股，成交量100.272万股，换手率1.41%，振幅6.87%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1390.94%、1116.23%、913.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"2514015658","title":"Viking Therapeutics, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514015658?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 23:27","pubTimestamp":1740497261,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时27分，Viking Therapeutics, Inc.股票出现波动，股价急速下跌5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1064.18%、913.07%、592.70%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232741abdc8ca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232741abdc8ca0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4599","BK4139","VKTX","LENZ"],"gpt_icon":0},{"id":"2514018334","title":"美股异动｜礼来涨超2.7% 推出10毫克剂量的小瓶装Zepbound","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018334","media":"港股那点事","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018334?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:42","pubTimestamp":1740494520,"startTime":"0","endTime":"0","summary":"格隆汇2月25日｜礼来(LLY.US)涨超2.7%，报905.4美元。消息面上，礼来公司宣布，畅销减肥药Zepbound 2.5毫克和5毫克规格的小瓶装产品月度价格将分别降至349美元和499美元，较此前降低约50美元。另外，礼来还推出了10毫克剂量的小瓶装Zepbound，月度价格为499美元。礼来公司高管表示，自Zepbound上市以来，已有超过10%的患者开始服用小剂量Zepbound。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-02-25/doc-inemtimv4271576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LLY","LU0079474960.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2491050071.SGD","LU1093756168.USD","BK4533","LU0354030438.USD","LU0672654240.SGD","SG9999001176.USD","BK4599","IE00BJLML261.HKD","LU0058720904.USD","LU0456855351.SGD","LU1057294990.SGD","BK4534","BK4007","SG9999014906.USD","LU0354030511.USD","LU0094547139.USD","IE00BJT1NW94.SGD","LU0256863902.USD","LU1868837300.USD","LU0061475181.USD","LU0114720955.EUR","LU2237443978.SGD","LU1868836914.USD","LU0640476718.USD","LU1814569148.SGD","LU0203201768.USD","IE0004445239.USD","LU2237443622.USD","LU2211815571.USD","LU2461242641.AUD","LU0820561818.USD","LU2491050154.USD","SGXZ99366536.SGD","LU0109391861.USD","LU1069344957.HKD","IE00B1BXHZ80.USD","LU1974910355.USD","LU1061106388.HKD","LU1623119135.USD","LU2023250504.SGD","LU2360106947.USD","SG9999015952.SGD","LU2237438978.USD","SG9999018857.SGD","LU2112291526.USD","LU1127390331.HKD"],"gpt_icon":0},{"id":"2514090106","title":"诺和诺德盘中异动 快速上涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514090106?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:34","pubTimestamp":1740494093,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时34分，诺和诺德股票出现异动，股价大幅拉升3.04%。诺和诺德股票所在的制药行业中，整体涨幅为1.62%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。时间回溯至2023年10月，诺和诺德以13亿美元的价格收购了KBP的核心在研药物Ocedurenone。为保障索赔权益，诺和诺德于2025年2月14日获得新加坡法院批准的全球资产冻结令，覆盖KBP在新加坡星展银行的2.18亿美元存款，以及黄振华价值700万美元的房产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223453962ff342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223453962ff342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU1093756168.USD","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD","NVO","BK4585","BK4532","LU0154236417.USD","BK4588","LU1093756325.SGD"],"gpt_icon":1},{"id":"2514091019","title":"BUZZ-礼来公司收购 Organovo FXR 项目，Organovo 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091019","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091019?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 21:42","pubTimestamp":1740490950,"startTime":"0","endTime":"0","summary":"2月25日 -  ** Organovo Holdings ONVO.O的股价盘前上涨两倍多，达到1.35美元 ** ONVO称 ，它正在向礼来LLY.N出售其FXR项目，包括主要资产FXR314。** LLY 将获得 Organovo FXR 项目的所有商业和知识产权，用于全球开发。** ONVO 表示，收购将使礼来公司能够从中期阶段开始进一步开发 FXR314 ** 2024 年，ONVO 下跌约 68(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","BK4139","LU2237443978.SGD","LU0354030511.USD","LU0708995401.HKD","SG9999015952.SGD","SG9999017495.SGD","LU1720051108.HKD","LU0203201768.USD","LU0096364046.USD","LU1267930730.SGD","LU2361045086.USD","ONVO","LLY","LU2357305700.SGD","LU0320765059.SGD","BK4599","LU2023250504.SGD","LU1868837300.USD","SG9999018865.SGD","LU1023059063.AUD","LU0820561818.USD","BK4581","LU1868836591.USD","SG9999001176.SGD","SG9999018857.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU0417517546.SGD","SG9999001176.USD","LU1868836757.USD","SG9999015986.USD","LU1069344957.HKD","LU1035775433.USD","SG9999013999.USD","LU0882574055.USD","LU0471298694.HKD","IE00B2B36J28.USD","LU2602419157.SGD","LU2361044949.HKD","LU2360106947.USD","LU0256863902.USD","LU2324357040.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","BK4585","LU1551013425.SGD","LU2237443382.USD","SGXZ51526630.SGD"],"gpt_icon":1},{"id":"2514096860","title":"礼来以折扣价提供瓶装减肥药以应对竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096860","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514096860?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:49","pubTimestamp":1740487772,"startTime":"0","endTime":"0","summary":"更新版 3-礼来以折扣价提供瓶装减肥药以应对竞争新定价旨在通过礼来直销吸引现金支付客户Hims & Hers警告称可能停止销售诺和诺德复方减肥药远程医疗公司股价下跌第 2-10 段增加了有关复方药物的细节和 Noom 首席执行官的评论Patrick  Wingrove/Sriparna  Roy. 路透社2月25日 - 礼来LLY.N周二表示，它将其减肥药Zepbound的小瓶售价下调了50美元或更多，并扩大了网上销售的剂量范围，以试图抵御来自复合药房和竞争对手诺和诺德NOVOb.CO的竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG150:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU1057294990.SGD","IE00BK4W5M84.HKD","IE00BJLML261.HKD","SG9999015945.SGD","SGXZ81514606.USD","SG9999018857.SGD","LU0471298777.SGD","LU0385154629.USD","LU1035775433.USD","LU2023250504.SGD","SG9999015986.USD","LU1804176565.USD","LU1868836591.USD","SGXZ51526630.SGD","LU1069344957.HKD","SGXZ31699556.SGD","LU1093756168.USD","LU2461242641.AUD","LU1861558580.USD","LU1712237335.SGD","LFMD","BK4588","LU0097036916.USD","LU0672654240.SGD","LU2063271972.USD","LU1127390331.HKD","LU0122379950.USD","LU2491049909.HKD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2361044865.SGD","BK4567","BK4533","BK4599","LU2237443465.HKD","LU1868837136.USD","IE00BFTCPJ56.SGD","BK4007","SG9999001176.SGD","LLY","SG9999014914.USD","LU1064131342.USD","LU0466842654.USD","LU2360106947.USD","LU0456855351.SGD","LU0198837287.USD","LU2361045086.USD"],"gpt_icon":1},{"id":"2514096548","title":"礼来美股盘前涨逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096548","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514096548?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:23","pubTimestamp":1740486220,"startTime":"0","endTime":"0","summary":"礼来美股盘前涨逾2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502253329223960.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502253329223960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1868836757.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU1035775433.USD","LU1804176565.USD","LU0122379950.USD","LU1093756168.USD","LU2324357040.USD","LU1974910355.USD","LU2237443382.USD","LU1868837300.USD","LU0198837287.USD","LU0943347566.SGD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU0471298694.HKD","LU0094547139.USD","LU0417517546.SGD","LU2106854487.HKD","IE00BFTCPJ56.SGD","LLY","LU0289739699.SGD","LU2237443622.USD","LU2211815571.USD","LU2491050154.USD","SG9999013999.USD","BK4007","LU1720051108.HKD","LU1093756325.SGD","LU2264538146.SGD","LU0109391861.USD","LU1868836591.USD","BK4599","LU0354030511.USD","GB00BDT5M118.USD","LU0882574055.USD","LU0096364046.USD","LU1551013342.USD","LU2361044949.HKD","BK4585","IE00BK4W5L77.USD","LU0689472784.USD","LU2063271972.USD","LU0820561818.USD","LU0456855351.SGD","LU2265009873.SGD","LU0114720955.EUR","LU0820561909.HKD","LU1366192091.USD","LU2237443895.HKD"],"gpt_icon":0},{"id":"2514093433","title":"BUZZ-礼来推出大剂量瓶装减肥药，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2514093433","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514093433?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:20","pubTimestamp":1740486048,"startTime":"0","endTime":"0","summary":"** 称已将低剂量小瓶药品一个月的供应量降价约 50 美元  ** LLY 在过去 12 个月中上涨了 14.5(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"83ee8187a7c6b491c0a55b1ec36d2adb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU1064131342.USD","LU1035775433.USD","SG9999015952.SGD","LU2237443622.USD","SG9999001176.USD","SG9999017495.SGD","IE00BJLML261.HKD","LU2264538146.SGD","LU2461242641.AUD","SG9999014898.SGD","LU0943347566.SGD","LU2491050154.USD","LU0289739699.SGD","SG9999013999.USD","LU0640476718.USD","LU1291159041.SGD","SGXZ57979304.SGD","LU2112291526.USD","LU2237438978.USD","LU2211815571.USD","BK4585","LU0456855351.SGD","LU1868837300.USD","LU0882574055.USD","LU1093756325.SGD","LU0466842654.USD","LU1069344957.HKD","LU2237443549.SGD","LU0689472784.USD","LU2360106947.USD","LU2361044865.SGD","LU0198837287.USD","LU1551013425.SGD","LLY","LU2106854487.HKD","BK4516","IE00BK4W5M84.HKD","SGXZ31699556.SGD","GB00BDT5M118.USD","IE00B4R5TH58.HKD","SG9999018865.SGD","SG9999015978.USD","LU2063271972.USD","IE00BJJMRZ35.SGD","LU0471298694.HKD","LU1804176565.USD","LU1023059063.AUD","BK4599","LU1974910355.USD"],"gpt_icon":0},{"id":"2514095509","title":"诺和诺德(NVO)盘前涨超4% 起诉美国药品监管机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095509","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095509?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:15","pubTimestamp":1740485735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)盘前涨超4%，截至发稿，报94.39美元。消息面上，华泰证券认为，GLP-1已展现较大的市场潜力，而目前海外MNC仅诺和诺德和礼来两巨头销售领先，但尚未形成完整产品矩阵，其他MNC产品仍处于临床阶段，竞争格局尚未定型，产品空缺较大。诺和诺德日前表示，继续按三班倒运作多家工厂，从而满足Wegovy和Ozempic需求。此外，据市场消息，药物配剂商就诺和诺德糖尿病、减肥药物从短缺名单中移除一事起诉美国药品监管机构。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"285776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","BK4588","LU0154236417.USD","LU1093756168.USD","BK4585","NVO","BK4532","LU1093756325.SGD"],"gpt_icon":0},{"id":"2514072060","title":"一次宇宙级合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2514072060","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514072060?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:05","pubTimestamp":1740485100,"startTime":"0","endTime":"0","summary":"01辉瑞目前的困境众所周知，宇宙药厂辉瑞在新冠期间靠疫苗和特效药发了横财，并且在2024年，它都是制药业务板块营收最高的MNC。排名第一的是派柏西利，治疗乳腺癌的CDK4/6抑制剂，小分子爆款单品的代表，排名第二的是恩杂鲁胺，治疗前列腺癌的抗雄激素受体小分子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","BK4139","SGXZ57979304.SGD","LU2089984988.USD","LU0058720904.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU1023059063.AUD","LU0170899867.USD","LU0203347892.USD","LU2468319806.SGD","BK4568","LU0320765489.SGD","LU0266013472.USD","LU1066053197.SGD","LU2023250843.SGD","LU0070302665.USD","LU1934455863.HKD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2361044949.HKD","BK4599","SG9999002224.SGD","LU1037948897.HKD","BK4550","LU0208291251.USD","LU1116320901.HKD","LU1934455277.USD","LU1983299246.USD","IE00BSNM7G36.USD","LU1894683264.USD","SMMT","BK4588","LU2106854487.HKD","BK4592","SG9999001176.SGD","PFE","MRK","SG9999014575.USD","LU2361045086.USD","LU1585245621.USD","LU1162221912.USD","SG9999013999.USD","SG9999001176.USD","LU0211331839.USD","LU0456855351.SGD","LU0006306889.USD","LU1989772840.SGD","LU0238689110.USD"],"gpt_icon":0},{"id":"2514060602","title":"礼来推出高剂量小瓶减肥药，价格比注射笔低 150 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060602","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060602?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:45","pubTimestamp":1740483904,"startTime":"0","endTime":"0","summary":"路透社2月25日 - 礼来LLY.N周二表示，该公司已开始在美国销售高剂量的流行减肥药Zepbound小瓶装，价格比注射笔版本便宜150美元，以刺激对该药的进一步需求。这比礼来公司向有保险但不在药品范围内的患者收取的 650 美元自动注射器费用低了近 23%。本周二，该公司表示已将这些剂量的一个月用量的价格分别下调了约50美元。礼来公司表示，患者必须在首次配药后 45 天内重新配药，才能获得相同的价格，否则重复配药的费用将高达 699 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG10F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035775433.USD","SG9999015952.SGD","LU1280957306.USD","LU0203202063.USD","LU0061475181.USD","LU1548497426.USD","LU0882574139.USD","LU1623119135.USD","IE00BJLML261.HKD","LU1917777945.USD","LU2461242641.AUD","LU1720051017.SGD","LU2491050154.USD","LU0289739699.SGD","SG9999013999.USD","LU0640476718.USD","IE00B1BXHZ80.USD","LU1291159041.SGD","LU2112291526.USD","LU2237438978.USD","LU0354030511.USD","LU1868836914.USD","LU1814569148.SGD","LU2468319806.SGD","LU0256863902.USD","LU0417517546.SGD","SG9999014880.SGD","SGXZ51526630.SGD","LU1069344957.HKD","LU2237443549.SGD","LU1127390331.HKD","LU2237443382.USD","LU0689472784.USD","LU0708995401.HKD","LU2361044865.SGD","SG9999018857.SGD","LU0820561909.HKD","LU0471298777.SGD","LLY","SG9999014906.USD","SGXZ31699556.SGD","LU1712237335.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU2063271972.USD","LU1804176565.USD","LU1023059063.AUD","BK4599","LU1974910355.USD","BK4533"],"gpt_icon":1},{"id":"2514706691","title":"诺和诺德美股盘前续涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514706691","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514706691?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 17:34","pubTimestamp":1740476068,"startTime":"0","endTime":"0","summary":"诺和诺德美股盘前续涨近4%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502253329082570.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502253329082570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BKVL7J92.USD","NVO","BK4599","BK4007","LU1093756325.SGD","BK4585","BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD"],"gpt_icon":0},{"id":"2514055452","title":"辉瑞任命前FDA药物主管为新任首席医疗官兼执行副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2514055452","media":"医药魔方","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514055452?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 15:11","pubTimestamp":1740467475,"startTime":"0","endTime":"0","summary":"2月24日，辉瑞宣布，前FDA药物主管Patrizia Cavazzoni将重新加入辉瑞，担任首席医疗官兼执行副总裁，领导辉瑞的监管、药物警戒、安全、流行病学、医疗信息和证据生成等医疗职能，并向辉瑞研发首席科学官兼总裁Chris Boshoff博士汇报。2019年，Cavazzoni加入FDA，担任代理首席副主任专员，并于2021年被任命为CDER的正式主任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225151629abdbf956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225151629abdbf956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0234572021.USD","LU0306806265.USD","LU1066051498.USD","IE00BLSP4452.SGD","LU0122379950.USD","SG9999002232.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU1066053197.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0289739699.SGD","LU0321505439.SGD","BK4585","SG9999003800.SGD","BK4592","BK4550","BK4599","LU0985481810.HKD","LU1894683264.USD","LU1883839398.USD","SG9999002224.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0306807586.USD","LU0058720904.USD","IE0002270589.USD","LU1057294990.SGD","SG9999013999.USD","LU1894683348.USD","SG9999001176.USD","IE00BLSP4239.USD","LU0225284248.USD","BK4581","PFE","BK4534","BK4007","BK4588","IE00B19Z3581.USD","SG9999001176.SGD","BK4568","LU0321505868.SGD","LU0868494617.USD","LU1023059063.AUD","LU0456855351.SGD","LU0225771236.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":7,"pageCount":4,"totalSize":108}]}}